Cergentis
Menu

Improved integration site analysis in cell and gene therapy manufacturing

18 March 2020Webinars

Sign up for our webinar* and learn about our Targeted Locus Amplification (TLA) technology and its applications in the complete next generation sequencing of transgenes and integration sites in cell and gene therapy products.

 

The following subjects will be discussed:

  • Principles of TLA
  • TLA-based transgene and integration site sequencing
  • Applications of TLA in cell and gene therapy manufacturing
  • Complete characterisation of producer cell lines
  • Assessment of downstream heterogeneous cell and gene therapy products
  • TLA-based clone selection, clonality and genetic stability assessment

 

*Registration is closed. Please click here to watch the recording of the webinar.

Overview
© 2012-2020 Cergentis B.V. All rights reserved.
For Research Use Only.Not for use in diagnostic procedures.